FdaApplication
BLA 103691
Identifiers
- fda_app_no: BLA103691
Properties
| Property | Value |
|---|---|
| applicant_name | Lynch Regenerative Medicine, LLC |
| application_type | BLA |
| approval_date | 1997-12-16 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| REGRANEX | BECAPLERMIN | 0.0001 | GEL;TOPICAL |
1 product